309 related articles for article (PubMed ID: 19656066)
1. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.
Pereyra F; Palmer S; Miura T; Block BL; Wiegand A; Rothchild AC; Baker B; Rosenberg R; Cutrell E; Seaman MS; Coffin JM; Walker BD
J Infect Dis; 2009 Sep; 200(6):984-90. PubMed ID: 19656066
[TBL] [Abstract][Full Text] [Related]
2. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
[TBL] [Abstract][Full Text] [Related]
3. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
Hatano H; Delwart EL; Norris PJ; Lee TH; Dunn-Williams J; Hunt PW; Hoh R; Stramer SL; Linnen JM; McCune JM; Martin JN; Busch MP; Deeks SG
J Virol; 2009 Jan; 83(1):329-35. PubMed ID: 18945778
[TBL] [Abstract][Full Text] [Related]
4. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
[TBL] [Abstract][Full Text] [Related]
5. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
[TBL] [Abstract][Full Text] [Related]
6. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
Karlsson AC; Younger SR; Martin JN; Grossman Z; Sinclair E; Hunt PW; Hagos E; Nixon DF; Deeks SG
AIDS; 2004 Apr; 18(7):981-9. PubMed ID: 15096800
[TBL] [Abstract][Full Text] [Related]
7. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
8. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
9. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
[TBL] [Abstract][Full Text] [Related]
10. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
11. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers.
García M; Morcilla V; Navarrete-Muñoz MÁ; Fisher K; Cabello A; López-Bernaldo JC; De La Hera F; Barros C; Fernández-Guerrero M; Estrada V; Górgolas M; Benito JM; Palmer S; Rallón N
AIDS; 2021 Mar; 35(3):393-398. PubMed ID: 33252487
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
13. Rapid development of HIV elite control in a patient with acute infection.
Morley D; Lambert JS; Hogan LE; De Gascun C; Redmond N; Rutishauser RL; Thanh C; Gibson EA; Hobbs K; Bakkour S; Busch MP; Farrell J; McGetrick P; Henrich TJ
BMC Infect Dis; 2019 Sep; 19(1):815. PubMed ID: 31533639
[TBL] [Abstract][Full Text] [Related]
14. Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.
Tjiam MC; Taylor JP; Morshidi MA; Sariputra L; Burrows S; Martin JN; Deeks SG; Tan DB; Lee S; Fernandez S; French MA
J Immunol; 2015 Jun; 194(11):5320-8. PubMed ID: 25911748
[TBL] [Abstract][Full Text] [Related]
15. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
[TBL] [Abstract][Full Text] [Related]
16. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
[TBL] [Abstract][Full Text] [Related]
17. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
Ostrowski SR; Katzenstein TL; Thim PT; Pedersen BK; Gerstoft J; Ullum H
J Infect Dis; 2005 Feb; 191(3):348-57. PubMed ID: 15633093
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral therapy on HIV reservoirs in elite controllers.
Chun TW; Shawn Justement J; Murray D; Kim CJ; Blazkova J; Hallahan CW; Benko E; Costiniuk CT; Kandel G; Ostrowski M; Kaul R; Moir S; Casazza JP; Koup RA; Kovacs C; Fauci AS
J Infect Dis; 2013 Nov; 208(9):1443-7. PubMed ID: 23847057
[TBL] [Abstract][Full Text] [Related]
19. A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.
Tomescu C; Liu Q; Ross BN; Yin X; Lynn K; Mounzer KC; Kostman JR; Montaner LJ
PLoS One; 2014; 9(7):e103209. PubMed ID: 25078947
[TBL] [Abstract][Full Text] [Related]
20. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
